Schizo-Obsessive Disorder: Case Study
Case Presentation A 20-year-old patient, high school student, lives with family. Nicotine addict, confirms occasional alcohol and marijuana use. In november 2019, the patient’s mental status was deteriorating. Patient was in ambulatory treatment with olanzapine and fluoxetine, but with no satisfactory results, which was the reason for the first psychiatric hospitalization in august 2020. Symptoms […]
Ocrelizumab in Relapsing-Remitting and Progressive Multiple Sclerosis
Ocrelizumab was found to be effective and safe therapy in relapsing-remitting, primary-progressive and secondary-progressive multiple sclerosis patients. Performed on 153 patients (mean age: 41.9 years; 60% females; mean EDSS: 3.5), this study provided first real-world effectiveness and safety data and the possible predictors of treatment response. After 2 years, percentage disability worsening-free patients were 90.5%, […]